Ranedis Pharmaceuticals | Rare and Neglected Diseases
15694
home,page,page-id-15694,page-template,page-template-full_width,page-template-full_width-php,ajax_fade,page_not_loaded,,qode-title-hidden,qode-theme-ver-10.1,wpb-js-composer js-comp-ver-5.0.1,vc_responsive
rnd_home

ADVANCING THE TREATMENT OF RARE AND NEGLECTED DISEASES

At Ranedis Pharmaceuticals we are focused on the treatment and management of rare and neglected diseases. 

 

Ranedis Pharmaceuticals is a development stage pharmaceutical company engaged in the development of a novel formulation of an HDAC inhibitor for the treatment of rare genetic, metabolic diseases.

Our Technology

Ranedis Pharmaceuticals’ technology was licensed from the University of Notre Dame.